These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12123718)

  • 61. Peroxisome proliferator-activated receptor-beta signaling contributes to enhanced proliferation of hepatic stellate cells.
    Hellemans K; Michalik L; Dittie A; Knorr A; Rombouts K; De Jong J; Heirman C; Quartier E; Schuit F; Wahli W; Geerts A
    Gastroenterology; 2003 Jan; 124(1):184-201. PubMed ID: 12512042
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Lipid metabolism: peroxisome proliferator-activated receptor-alpha and atherosclerosis.
    van Greevenbroek MM; van der Kallen CJ
    Curr Opin Lipidol; 2002 Apr; 13(2):223-5. PubMed ID: 11891425
    [No Abstract]   [Full Text] [Related]  

  • 63. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Induction of apoptosis in mouse T cells upon peroxisome proliferator-activated receptor gamma (PPAR-gamma) binding.
    Harris SG; Phipps RP
    Adv Exp Med Biol; 2002; 507():421-5. PubMed ID: 12664620
    [No Abstract]   [Full Text] [Related]  

  • 65. Regulation of triacylglycerol hydrolase expression by dietary fatty acids and peroxisomal proliferator-activated receptors.
    Dolinsky VW; Gilham D; Hatch GM; Agellon LB; Lehner R; Vance DE
    Biochim Biophys Acta; 2003 Nov; 1635(1):20-8. PubMed ID: 14642773
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Application of fluorescent differential display and peroxisome proliferator-activated receptor (PPAR) alpha-null mice to analyze PPAR target genes.
    Lee SS; Tian L; Lee WS; Cheung WT
    Methods Enzymol; 2002; 357():214-40. PubMed ID: 12424913
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis.
    Harman FS; Nicol CJ; Marin HE; Ward JM; Gonzalez FJ; Peters JM
    Nat Med; 2004 May; 10(5):481-3. PubMed ID: 15048110
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Peroxisome proliferator activated receptors: transcriptional regulators of adipogenesis, lipid metabolism and more...
    Wahli W; Braissant O; Desvergne B
    Chem Biol; 1995 May; 2(5):261-6. PubMed ID: 9383428
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Mechanism of the onset and development of nonalcoholic steatohepatitis and PPAR].
    Tanaka N; Aoyama T
    Nihon Shokakibyo Gakkai Zasshi; 2002 Jun; 99(6):563-9. PubMed ID: 12099000
    [No Abstract]   [Full Text] [Related]  

  • 70. Fatty acid regulation of gene transcription.
    Duplus E; Glorian M; Forest C
    J Biol Chem; 2000 Oct; 275(40):30749-52. PubMed ID: 10934217
    [No Abstract]   [Full Text] [Related]  

  • 71. The adipocyte: storage depot or node on the energy information superhighway?
    Flier JS
    Cell; 1995 Jan; 80(1):15-8. PubMed ID: 7813011
    [No Abstract]   [Full Text] [Related]  

  • 72. Lipid metabolism.
    Poisson JP
    Curr Opin Lipidol; 1998 Feb; 9(1):67-8. PubMed ID: 9502338
    [No Abstract]   [Full Text] [Related]  

  • 73. Lipid metabolism.
    Poisson JP
    Curr Opin Lipidol; 1997 Apr; 8(2):U20-1. PubMed ID: 9183554
    [No Abstract]   [Full Text] [Related]  

  • 74. The new therapeutic frontier--nuclear receptors and the liver.
    Karpen SJ; Trauner M
    J Hepatol; 2010 Mar; 52(3):455-62. PubMed ID: 20133000
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Generation and functional confirmation of a conditional null PPARgamma allele in mice.
    Jones JR; Shelton KD; Guan Y; Breyer MD; Magnuson MA
    Genesis; 2002 Feb; 32(2):134-7. PubMed ID: 11857800
    [No Abstract]   [Full Text] [Related]  

  • 76. Enteric Microbiota⁻Gut⁻Brain Axis from the Perspective of Nuclear Receptors.
    Duszka K; Wahli W
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060580
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PPARs and Mitochondrial Metabolism: From NAFLD to HCC.
    Mello T; Materozzi M; Galli A
    PPAR Res; 2016; 2016():7403230. PubMed ID: 28115925
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction.
    Lecarpentier Y; Claes V; Duthoit G; Hébert JL
    Front Physiol; 2014; 5():429. PubMed ID: 25414671
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect.
    Yan F; Wang Q; Xu C; Cao M; Zhou X; Wang T; Yu C; Jing F; Chen W; Gao L; Zhao J
    PLoS One; 2014; 9(6):e99245. PubMed ID: 24926685
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PPARs Integrate the Mammalian Clock and Energy Metabolism.
    Chen L; Yang G
    PPAR Res; 2014; 2014():653017. PubMed ID: 24693278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.